# Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects

> **NCT05711797** · PHASE1 · COMPLETED · sponsor: **Nanjing Zenshine Pharmaceuticals** · enrollment: 16 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **DRUG:** ZX-7101A 80mg

## Key facts

- **NCT ID:** NCT05711797
- **Lead sponsor:** Nanjing Zenshine Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-12
- **Primary completion:** 2024-02-06
- **Final completion:** 2024-08-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05711797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05711797, "Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05711797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*